Media

All media enquiries: media@cognitotx.com

Cognito Therapeutics CEO Brent Vaughan to Speak at CODE Conference 2021

September 15, 2021

Cognito Therapeutics Announces Formation of Payor Advisory Board

September 8, 2021

Cognito Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2021

August 4, 2021

Cognito Therapeutics Presents New Clinical Data Demonstrating Disease-Modifying Effects of Gamma Frequency Neuro-modulation on Cognitive Function and Brain Atrophy in Alzheimer’s Disease at AAIC 2021

July 26, 2021

Cognito Therapeutics Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2021

July 14, 2021

Cognito Therapeutics Appoints Gerald Chan as Chairman of the Board

July 6, 2021

Cognito Therapeutics Initiates Studies in Down Syndrome Associated Alzheimer’s Disease

June 14, 2021

Cognito Therapeutics Appoints Everett Crosland as Chief Commercial Officer

May 18, 2021

Cognito Therapeutics to Advance Digital Therapeutic for Alzheimer’s into Pivotal Studies Based on Positive Clinical Results Announced at AD/PD 2021

March 17, 2021